Literature DB >> 27429211

Obesity and cancer: inflammation bridges the two.

Ryan Kolb1, Fayyaz S Sutterwala2, Weizhou Zhang3.   

Abstract

Obesity is a growing public health problem and affects 35% US adults. Obesity increases the risk of many cancer types and is associated with poor outcomes. Clinical management of cancer patients has been essentially the same between normal weight and obese individuals. Understanding causal mechanisms by which obesity drives cancer initiation and progression is essential for the development of novel precision therapy for obese cancer patients. One caveat is that various mechanisms have been proposed for different cancer types for their progression under obesity. Since obesity is known to have global impact on inflammation, here we will summarize recent literature and discuss the potential of inflammation being the common causal mechanism to promote cancer promotion across cancer types.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27429211      PMCID: PMC4992602          DOI: 10.1016/j.coph.2016.07.005

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  149 in total

1.  Serum adiponectin is not associated with risk of colorectal cancer.

Authors:  Annekatrin Lukanova; Stefan Söderberg; Rudolf Kaaks; Egil Jellum; Pär Stattin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

Review 2.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

Authors:  Nathalie Esser; Sylvie Legrand-Poels; Jacques Piette; André J Scheen; Nicolas Paquot
Journal:  Diabetes Res Clin Pract       Date:  2014-04-13       Impact factor: 5.602

Review 3.  Significance of interleukin-6 (IL-6) in breast cancer (review).

Authors:  Heike Knüpfer; Rainer Preiss
Journal:  Breast Cancer Res Treat       Date:  2006-08-23       Impact factor: 4.872

4.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

5.  Components of the metabolic syndrome and colorectal cancer risk; a prospective study.

Authors:  T Stocks; A Lukanova; M Johansson; S Rinaldi; R Palmqvist; G Hallmans; R Kaaks; P Stattin
Journal:  Int J Obes (Lond)       Date:  2007-09-18       Impact factor: 5.095

6.  Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway.

Authors:  Michiko Sugiyama; Hirokazu Takahashi; Kunihiro Hosono; Hiroki Endo; Shingo Kato; Kyoko Yoneda; Yuichi Nozaki; Koji Fujita; Masato Yoneda; Koichiro Wada; Hitoshi Nakagama; Atsushi Nakajima
Journal:  Int J Oncol       Date:  2009-02       Impact factor: 5.650

7.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

8.  Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience.

Authors:  G Berclaz; S Li; K N Price; A S Coates; M Castiglione-Gertsch; C-M Rudenstam; S B Holmberg; J Lindtner; D Erien; J Collins; R Snyder; B Thürlimann; M F Fey; C Mendiola; I Dudley Werner; E Simoncini; D Crivellari; R D Gelber; A Goldhirsch
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

9.  Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.

Authors:  Enrique Fuentes-Mattei; Guermarie Velazquez-Torres; Liem Phan; Fanmao Zhang; Ping-Chieh Chou; Ji-Hyun Shin; Hyun Ho Choi; Jiun-Sheng Chen; Ruiying Zhao; Jian Chen; Chris Gully; Colin Carlock; Yuan Qi; Ya Zhang; Yun Wu; Francisco J Esteva; Yongde Luo; Wallace L McKeehan; Joe Ensor; Gabriel N Hortobagyi; Lajos Pusztai; W Fraser Symmans; Mong-Hong Lee; Sai-Ching Jim Yeung
Journal:  J Natl Cancer Inst       Date:  2014-06-23       Impact factor: 13.506

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  83 in total

Review 1.  Cellular determinants and therapeutic implications of inflammation in pancreatic cancer.

Authors:  Meredith L Stone; Gregory L Beatty
Journal:  Pharmacol Ther       Date:  2019-05-31       Impact factor: 12.310

2.  Adipose tissue: The dysfunctional adipocyte - a cancer cell's best friend.

Authors:  Zhuzhen Zhang; Philipp E Scherer
Journal:  Nat Rev Endocrinol       Date:  2018-01-05       Impact factor: 43.330

Review 3.  Gender Differences in Obesity-Related Cancers.

Authors:  Georgia Argyrakopoulou; Maria Dalamaga; Nikolaos Spyrou; Alexander Kokkinos
Journal:  Curr Obes Rep       Date:  2021-02-01

4.  Body mass index as an independent prognostic factor in glioblastoma.

Authors:  Pedro Valente Aguiar; Bruno Carvalho; Rui Vaz; Paulo Linhares
Journal:  Cancer Causes Control       Date:  2021-01-15       Impact factor: 2.506

5.  Impact of Bariatric Surgery on Endometrial Cancer Tumor Pathology.

Authors:  David A Mahvi; Olivia W Foley; Ali Ardestani; Ali Tavakkoli; Eric G Sheu
Journal:  Obes Surg       Date:  2021-02-18       Impact factor: 4.129

6.  Obesity and Risk for Second Malignant Neoplasms in Childhood Cancer Survivors: A Case-Control Study Utilizing the California Cancer Registry.

Authors:  Diana J Moke; Ann S Hamilton; Leena Chehab; Dennis Deapen; David R Freyer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07-23       Impact factor: 4.254

Review 7.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

Review 8.  Myeloid derived-suppressor cells: their role in cancer and obesity.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  2018-03-13       Impact factor: 7.486

9.  Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study.

Authors:  Catherine Schairer; Cecile A Laurent; Lisa M Moy; Gretchen L Gierach; Neil E Caporaso; Ruth M Pfeiffer; Lawrence H Kushi
Journal:  Breast Cancer Res Treat       Date:  2020-07-20       Impact factor: 4.872

10.  Obesity and telomere status in the prognosis of patients with colorectal cancer submitted to curative intention surgical treatment.

Authors:  Sergio García-Martínez; Daniel González-Gamo; Tamara Fernández-Marcelo; Sofía Tesolato; Sofía De La Serna; Inmaculada Domínguez-Serrano; Oscar Cano-Valderrama; Ana Barabash; Carmen De Juan; Antonio Torres-García; Pilar Iniesta
Journal:  Mol Clin Oncol       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.